(TRMD) Torm - Overview
Stock: Tanker Fleet, Marine Engineering, Oil Transport, Shipping
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 10.22% |
| Yield on Cost 5y | 45.19% |
| Yield CAGR 5y | -0.33% |
| Payout Consistency | 59.6% |
| Payout Ratio | 106.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.5% |
| Relative Tail Risk | -3.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 21.34 |
| Character TTM | |
|---|---|
| Beta | 0.629 |
| Beta Downside | 1.016 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.59% |
| CAGR/Max DD | 0.20 |
Description: TRMD Torm January 16, 2026
TORM plc (NASDAQ: TRMD) is a UK-based shipping group that operates a fleet of product tankers and a marine-engineering business that designs and builds low-emission equipment for vessels. The Tanker segment moves refined petroleum products (e.g., gasoline, jet fuel, kerosene) and “dirty” fuels such as fuel oil, while the Marine Engineering segment focuses on advanced, greener ship-propulsion solutions.
As of the latest disclosed quarter (Q3 2024), TORM’s fleet comprises roughly 30 product tankers with an average age of 6 years, giving it a competitive advantage in fuel-efficiency and compliance with IMO 2020 sulfur caps. EBITDA for the quarter was $210 million, reflecting a 12 % uplift year-over-year, driven primarily by higher freight rates on the Baltic Dirty Tanker Index and robust demand for refined product transport in Asia-Europe trade lanes. A key sector driver is the ongoing shift toward low-sulfur and decarbonised fuels, which is expected to boost demand for TORM’s green marine equipment.
Given the tight supply of modern product tankers and the accelerating regulatory push for greener shipping, TORM’s exposure to both freight-rate upside and marine-engineering growth could be material; however, earnings remain sensitive to global oil demand cycles and any abrupt changes in freight-rate volatility.
For a deeper quantitative dive into TORM’s valuation metrics and scenario analysis, you might find ValueRay’s analyst tools useful.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 276.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.62 > 1.0 |
| NWC/Revenue: 23.02% < 20% (prev 25.21%; Δ -2.18% < -1%) |
| CFO/TA 0.15 > 3% & CFO 479.4m > Net Income 276.9m |
| Net Debt (677.1m) to EBITDA (567.8m): 1.19 < 3 |
| Current Ratio: 2.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (100.8m) vs 12m ago 3.92% < -2% |
| Gross Margin: 47.24% > 18% (prev 0.62%; Δ 4662 % > 0.5%) |
| Asset Turnover: 39.18% > 50% (prev 48.08%; Δ -8.90% > 0%) |
| Interest Coverage Ratio: 4.61 > 6 (EBITDA TTM 567.8m / Interest Expense TTM 77.3m) |
Altman Z'' 5.14
| A: 0.09 (Total Current Assets 515.7m - Total Current Liabilities 218.1m) / Total Assets 3.19b |
| B: 0.53 (Retained Earnings 1.69b / Total Assets 3.19b) |
| C: 0.11 (EBIT TTM 356.6m / Avg Total Assets 3.30b) |
| D: 1.97 (Book Value of Equity 2.05b / Total Liabilities 1.04b) |
| Altman-Z'' Score: 5.14 = AAA |
Beneish M -2.87
| DSRI: 1.20 (Receivables 208.3m/220.1m, Revenue 1.29b/1.64b) |
| GMI: 1.31 (GM 47.24% / 61.76%) |
| AQI: 0.88 (AQ_t 0.00 / AQ_t-1 0.00) |
| SGI: 0.79 (Revenue 1.29b / 1.64b) |
| TATA: -0.06 (NI 276.9m - CFO 479.4m) / TA 3.19b) |
| Beneish M-Score: -2.87 (Cap -4..+1) = A |
What is the price of TRMD shares?
Over the past week, the price has changed by +2.30%, over one month by +21.64%, over three months by +14.67% and over the past year by +35.24%.
Is TRMD a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TRMD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27 | 8.4% |
| Analysts Target Price | 27 | 8.4% |
| ValueRay Target Price | 30.1 | 20.8% |
TRMD Fundamental Data Overview February 03, 2026
P/E Forward = 11.7925
P/S = 1.9407
P/B = 1.1439
Revenue TTM = 1.29b USD
EBIT TTM = 356.6m USD
EBITDA TTM = 567.8m USD
Long Term Debt = 777.5m USD (from longTermDebt, last quarter)
Short Term Debt = 121.4m USD (from shortTermDebt, last quarter)
Debt = 895.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 677.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.18b USD (2.51b + Debt 895.9m - CCE 218.8m)
Interest Coverage Ratio = 4.61 (Ebit TTM 356.6m / Interest Expense TTM 77.3m)
EV/FCF = 13.16x (Enterprise Value 3.18b / FCF TTM 242.0m)
FCF Yield = 7.60% (FCF TTM 242.0m / Enterprise Value 3.18b)
FCF Margin = 18.72% (FCF TTM 242.0m / Revenue TTM 1.29b)
Net Margin = 21.42% (Net Income TTM 276.9m / Revenue TTM 1.29b)
Gross Margin = 47.24% ((Revenue TTM 1.29b - Cost of Revenue TTM 682.1m) / Revenue TTM)
Gross Margin QoQ = 36.25% (prev 50.16%)
Tobins Q-Ratio = 1.00 (Enterprise Value 3.18b / Total Assets 3.19b)
Interest Expense / Debt = 2.65% (Interest Expense 23.7m / Debt 895.9m)
Taxrate = 1.52% (1.20m / 78.9m)
NOPAT = 351.1m (EBIT 356.6m * (1 - 1.52%))
Current Ratio = 2.37 (Total Current Assets 515.7m / Total Current Liabilities 218.1m)
Debt / Equity = 0.42 (Debt 895.9m / totalStockholderEquity, last quarter 2.14b)
Debt / EBITDA = 1.19 (Net Debt 677.1m / EBITDA 567.8m)
Debt / FCF = 2.80 (Net Debt 677.1m / FCF TTM 242.0m)
Total Stockholder Equity = 2.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.39% (Net Income 276.9m / Total Assets 3.19b)
RoE = 13.08% (Net Income TTM 276.9m / Total Stockholder Equity 2.12b)
RoCE = 12.32% (EBIT 356.6m / Capital Employed (Equity 2.12b + L.T.Debt 777.5m))
RoIC = 10.88% (NOPAT 351.1m / Invested Capital 3.23b)
WACC = 6.75% (E(2.51b)/V(3.40b) * Re(8.23%) + D(895.9m)/V(3.40b) * Rd(2.65%) * (1-Tc(0.02)))
Discount Rate = 8.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.35%
[DCF Debug] Terminal Value 78.81% ; FCFF base≈271.1m ; Y1≈204.2m ; Y5≈122.7m
Fair Price DCF = 22.93 (EV 3.00b - Net Debt 677.1m = Equity 2.32b / Shares 101.3m; r=6.75% [WACC]; 5y FCF grow -29.23% → 2.90% )
EPS Correlation: -69.77 | EPS CAGR: -38.07% | SUE: -4.0 | # QB: 0
Revenue Correlation: 30.24 | Revenue CAGR: 17.21% | SUE: 0.70 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=-0.270 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=2.67 | Chg30d=+0.910 | Revisions Net=+0 | Growth EPS=+0.2% | Growth Revenue=-14.1%